Chemotherapy,volume 58,issue 1  (02-2012)

Period of time： 2012年1期

Publisher： Karger

Founded in： 1960

Total resources： 110

E-ISSN： 1421-9794|58|1

ISSN： 0009-3157

Subject： R96 Pharmacology

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Chemotherapy,volume 58,issue 1

Menu

A Phase II Study of Capecitabine plus Oxaliplatin as First-Line Chemotherapy in Elderly Patients with Advanced Gastric Cancer

Chemotherapy,volume 58,issue 1 , Vol. 58, Iss. 1, 2012-02 , pp. 1-7

Karger

Abstract Access to resources Recommend Favorite

Risk and Healthcare Costs of Chemotherapy-Induced Neutropenic Complications in Women with Metastatic Breast Cancer

Chemotherapy,volume 58,issue 1 , Vol. 58, Iss. 1, 2012-02 , pp. 8-18

Karger

Abstract Access to resources Recommend Favorite

DNMT Inhibitors and HDAC Inhibitors Regulate E-Cadherin and Bcl-2 Expression in Endometrial Carcinoma in vitro and in vivo

Chemotherapy,volume 58,issue 1 , Vol. 58, Iss. 1, 2012-02 , pp. 19-29

Karger

Abstract Access to resources Recommend Favorite

Neoadjuvant Use of Sunitinib in Locally Advanced GIST with Intolerance to Imatinib

Chemotherapy,volume 58,issue 1 , Vol. 58, Iss. 1, 2012-02 , pp. 30-33

Karger

Abstract Access to resources Recommend Favorite

Naturally Occurring Cutaneous Anthrax: Antibiotic Treatment and Outcome

Chemotherapy,volume 58,issue 1 , Vol. 58, Iss. 1, 2012-02 , pp. 34-43

Karger

Abstract Access to resources Recommend Favorite

Synergistic Effects of Combination Treatment with Bortezomib and Doxorubicin in Human Neuroblastoma Cell Lines

Chemotherapy,volume 58,issue 1 , Vol. 58, Iss. 1, 2012-02 , pp. 44-51

Karger

Abstract Access to resources Recommend Favorite

Prevalence of Fluoroquinolone-Resistant Escherichia coli O25:H4-ST131 (CTX-M-15-Nonproducing) Strains Isolated in Japan

Chemotherapy,volume 58,issue 1 , Vol. 58, Iss. 1, 2012-02 , pp. 52-59

Karger

Abstract Access to resources Recommend Favorite

The Qualification of Docetaxel or Erlotinib for Second-Line Therapy Should Be Based on Clinical and Molecular Predictive Factors

Chemotherapy,volume 58,issue 1 , Vol. 58, Iss. 1, 2012-02 , pp. 60-69

Karger

Abstract Access to resources Recommend Favorite

Melissa officinalis Extract Inhibits Attachment of Herpes Simplex Virus in vitro

Chemotherapy,volume 58,issue 1 , Vol. 58, Iss. 1, 2012-02 , pp. 70-77

Karger

Abstract Access to resources Recommend Favorite

A Phase II Study of First-Line Chemotherapy with Weekly Carboplatin Plus Gemcitabine in Advanced Non-Small Cell Lung Cancer

Chemotherapy,volume 58,issue 1 , Vol. 58, Iss. 1, 2012-02 , pp. 78-83

Karger

Abstract Access to resources Recommend Favorite

Previous 1 2 Next Display item(s) per page Total 11 item(s)